tiprankstipranks
Terns Pharmaceuticals (TERN)
NASDAQ:TERN
US Market
TERN
Terns Pharmaceuticals
RESEARCH TOOLSreports
Want to see TERN full AI Analyst Report?

Terns Pharmaceuticals (TERN) Income Statement

540 Followers

Terns Pharmaceuticals Income Statement

Last quarter (Q4 2025), Terns Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Terns Pharmaceuticals's net income was $-23.57M. See Terns Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 1.00M
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 1.00M
Operating Expenses
$ 110.12M$ 101.87M$ 102.56M$ 62.03M$ 50.86M
Depreciation and Amortization
$ 0.00$ 896.00K$ 881.00K$ 1.03M$ 512.00K
EBITDA
$ -110.12M$ -100.97M$ -101.68M$ -61.00M$ -49.35M
Operating Income
$ -110.12M$ -101.87M$ -102.56M$ -62.03M$ -49.86M
Other Income/Expenses
$ 14.50M$ 13.28M$ 12.59M$ 2.04M$ 210.00K
Pretax Income
$ -95.63M$ -88.59M$ -89.97M$ -59.99M$ -49.65M
Net Income
$ -96.21M$ -88.85M$ -90.21M$ -60.34M$ -50.16M
Per Share Metrics
Basic EPS
$ -1.03$ -1.12$ -1.27$ -1.67$ -1.98
Diluted EPS
$ -1.03$ -1.12$ -1.27$ -1.67$ -1.98
Weighted Average Shares Outstanding
 93.17M 79.51M 71.26M 36.03M 25.27M
Weighted Average Shares Outstanding (Diluted)
 93.17M 79.51M 71.26M 36.03M 25.27M
Currency in USD

Terns Pharmaceuticals Earnings and Revenue History